ArticleFrontiers in oncology2025
Development, feasibility and usability of an app for the correct nutrition of children and adolescents with acute lymphoblastic leukemia.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A nomogram for risk stratification of protein-energy malnutrition in pediatric cancer patients: development and internal validation.Scientific reports · 2026Article
- Evaluating function availability and user satisfaction with nutrition apps: user-generated content analysis and text mining study.Nutrition journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Proper nutrition during cancer treatment is crucial for children and adolescents with acute lymphoblastic leukemia (ALL), as malnutrition can impact treatment tolerance, survival, and quality of life. In ALL specifically, malnutrition at diagnosis has been associated with increased risk of infections, treatment delays, and poorer survival, while maintaining adequate nutritional status can improve treatment tolerance and long-term outcomes. Materials and methods: We developed and tested the "Hematognam" app, which provides caregivers with dietary guidance for children and adolescents undergoing chemotherapy. This study evaluates the app's feasibility and usability among families of children and adolescents with ALL over a three-month period. Results: The app received high satisfaction ratings, which suggests its user-centric design and relevance in managing complex dietary challenges associated with treatment. Discussion: These results align with previous studies demonstrating the potential of digital health tools to enhance treatment compliance and overall well-being in vulnerable populations. By addressing key nutritional challenges faced by children and adolescents with ALL - such as appetite loss, food aversions, gastrointestinal side effects, and food safety concerns - the "Hematognam" app offers a complementary tool to existing dietary counseling, supporting both families and clinicians in daily nutritional management. The development and implementation of the "Hematognam" app proved feasible and effective in addressing the nutritional needs of children and adolescents with ALL during chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.